Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immunoglobulin E as a promising new form of anti-cancer immunotherapy

05.06.2018

If immunoglobulin E (IgE) antibodies are directed against harmless antigens such as pollen, the result can be an allergic reaction. However the original purpose of these IgE antibodies is to repel harmful exogenous substances rather than to trigger allergies. In collaboration with Vetmeduni Vienna and international scientists, researchers from MedUni Vienna have now made use this function: they have developed a "canine IgE" that directly targets the EGFR growth factor in cancerous tumours. The main finding: in-vitro studies showed that the tumour was destroyed by the IgE antibodies in more than 60% of cases.

The response of endogenous immunoglobulin E that leads to the development of allergies is "pointless", because it interacts with inflammatory cells to turn against harmless antigens , thereby causing serious allergies.


A new immunoglobulin E specialised for dogs may be an effective support in cancer therapy.

Michael Bernkopf/Vetmeduni Vienna

"Our motto in the current study is: Is there any point to IgE?" says its lead author, Erika Jensen-Jarolim, who has dual affiliation, both to MedUni Vienna's Institute of Pathophysiology and Allergy Research and to the inter-university Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University of Vienna and University of Vienna.

"Using dogs as ' model patients’, we were able to show that tumours that have the EGFR growth factor can be killed by immunoglobulin E, irrespective of the breed of dog," explains Jensen-Jarolim. By the way, the 3rd of June is "Day of the Dog".

The results of the study, which have now been published in leading magazine "Journal of Allergy and Clinical Immunology" (JACI), are also highly promising, since canine EGFR is a 92% match for human EGFR. IgE antibodies build a "bridge", as it were, between the EGFR on cancer cells and the inflammatory cells, thereby releasing tumour necrosis factors – which immediately start to kill the tumours.

Says Jensen-Jarolim: "We can therefore hope that we have made an important contribution towards developing a new form of immunotherapy against cancerous tumours. A subsequent clinical trial will be conducted in canine patients to validate the results in an international joint initiative before moving to human trials. "This paper is a perfect example of what we are all about at the Messerli Research Institute: improving medicine for people but for animals as well."

Service:
"AllergoOncology: Generating a canine anti-cancer IGE against the epidermal growth factor receptor (EGFR)". J. Fazakas-Singer, J. Singer, K. Ilieva, M. Matz, I. Herrmann, E. Spillner, S. Karagiannis, E. Jensen-Jarolim. Journal of Allergy and Clinical Immunology, June 2018. doi: 10.1016/j.jaci.2018.04.021. Link: https://www.ncbi.nlm.nih.gov/pubmed/29746883.

About the University of Veterinary Medicine, Vienna
The University of Veterinary Medicine, Vienna in Austria is one of the leading academic and research institutions in the field of Veterinary Sciences in Europe. About 1,300 employees and 2,300 students work on the campus in the north of Vienna which also houses five university clinics and various research sites. Outside of Vienna the university operates Teaching and Research Farms. The Vetmeduni Vienna plays in the global top league: in 2017, it occupies the excellent place 8 in the world-wide Shanghai University veterinary in the subject "Veterinary Science". http://www.vetmeduni.ac.at

Scientific Contact:
Erika Jensen-Jarolim
Comparative Medicine, Messerli Research Institute
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-2660
erika.jensen-jarolim@vetmeduni.ac.at

Released by:
Georg Mair
Science Communication / Corporate Communications
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-1165
georg.mair@vetmeduni.ac.at

Medical University Vienna - short profile
Medical University Vienna (MedUni Vienna) is one of the most traditional medical education and research facilities in Europe. With almost 8,000 students, it is currently the largest medical training centre in the German-speaking countries. With 5,500 employees, 26 departments and three clinical institutes, 12 medical theory centres and numerous highly specialised laboratories, it is also one of Europe's leading research establishments in the biomedical sector.

About Messerli Research Institute
The Messerli Research Institute was founded in 2010 with support from the Messerli Foundation (Sörenberg, Switzerland) under the management of the University of Veterinary Medicine, Vienna in cooperation with the Medical University of Vienna and the University of Vienna. The research is devoted to the interaction between humans and animals, as well as its theoretical principles in animal cognition and behavior, comparative medicine and ethics. Its work is characterized by its broad interdisciplinary approach (biology, human medicine, veterinary medicine, philosophy, psychology, law) and strong international focus. http://www.vetmeduni.ac.at/en/messerli/

Weitere Informationen:

http://www.vetmeduni.ac.at/en/infoservice/presseinformation/presse-releases-2018...

Mag.rer.nat. Georg Mair | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>